Moving Science Closer to Health

On average, it takes at least 10 years to move a drug from molecule to medicine.1 That is far too long. That’s why, with the discipline of precision medicine as our foundation, Precision Medicine Group has brought together targeted expertise that can propel drug development and access forward. We apply relevant insights and specialized capabilities to unlock the potential of data, speed drug development, and deploy messaging for commercial success. The result: We accelerate the delivery of life science innovations—so that exciting new therapies can advance human health.

Next-gen clinical development

Accelerating clinical research and development
through the combined power of trials, labs,
and data science.

Learn More

Next-gen commercialization

Demonstrating the value of life-science innovations
with evidence and real-world expertise.

Learn More



Delivering high-yield insights that unlock the full
potential of data to power clinical development
and commercial success

Learn More


the gene & cell therapy collective

Anticipating and shaping the next generation
of drug development and commercialization
for gene and cell therapies

Learn More


Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020

Read More


Precision for Medicine Partners with Karyopharm Therapeutics to Initiate New Global Clinical Trial to Treat Patients with COVID-19

Read More


Precision Value & Health Shifts the Trajectory with Convergence of Brands under One Umbrella

Read More


Precision For Medicine Taps Mairead Kehoe as Executive Vice President, Clinical Solutions

Read More